Biosynthetic Pathways of Natural Antibiotic Compounds

Natural antibiotic compounds originate from complex enzymatic assembly lines encoded within biosynthetic gene clusters. These clusters direct the stepwise construction of diverse molecular scaffolds through the action of polyketide synthases, nonribosomal peptide synthetases and associated tailoring enzymes. Structural variations such as unusual amino acids, halogenations, glycosylations and diazo modifications arise from dedicated modules or discrete accessory proteins, conferring potent bioactivity and often novel modes of action. Advances in genomics, structural biology and synthetic biology have illuminated the reaction mechanisms and intermodule coordination that underpin these pathways. Such insights fuel rational engineering efforts to enhance yields, extend chemical diversity and overcome antimicrobial resistance, underscoring the global significance of harnessing microbial biosynthesis for next-generation therapeutics.

Research from Nature Portfolio

Recent studies have elucidated the structural basis of a potent peptide antibiotic’s mechanism by cryo-electron microscopy, revealing how dual binding to bacterial DNA gyrase locks the enzyme in a non-productive state and prevents DNA religation. Synthetic analogues designed from this structure exhibit improved solubility and activity against fluoroquinolone-resistant pathogens. Parallel work on nonribosomal peptides uncovered a novel termination module that installs a C-terminal putrescine moiety via direct condensation, a process engineered into other synthetases to enhance peptide hydrophilicity and antimicrobial potency. Foundational investigations into ilamycin biosynthesis have mapped the incorporation of rare L-3-nitrotyrosine and L-2-amino-4-hexenoic acid residues, identifying pre-tailoring and post-tailoring steps through gene inactivations, isotope feeding and intermediate characterisation. Genetically optimised strains now produce ilamycin congeners with nanomolar anti-tuberculosis activity, illustrating the power of pathway dissection and engineering for drug lead development.

Biosynthetic Pathways of Natural Antibiotic Compounds publication trend

The graph below shows the total number of articles in biosynthetic pathways of natural antibiotic compounds across all publications each year (not limited to Nature Index journals).

Technical terms

Biosynthetic gene cluster: co-localised genes encoding enzymes for the assembly of a secondary metabolite.

Nonribosomal peptide synthetase: large multi-domain enzyme that assembles peptides independently of ribosomes using an assembly-line mechanism.

Polyketide synthase: modular enzyme complex that condenses acyl-CoA precursors to build diverse polyketide scaffolds.

Cryo-electron microscopy: imaging technique that determines molecular structures at near-atomic resolution under cryogenic conditions.

α-Diazoester: compound featuring a diazo (–N₂) moiety adjacent to an ester, serving as a carbene precursor.

Megasynthase: collective term for large enzyme complexes such as NRPS and PKS that function as molecular assembly lines.

References

1. Molecular mechanism of topoisomerase poisoning by the peptide antibiotic albicidin. Nature Catalysis (2023).
2. Biosynthesis and engineering of the nonribosomal peptides with a C-terminal putrescine. Nature Communications (2023).
3. Biosynthesis of ilamycins featuring unusual building blocks and engineered production of enhanced anti-tuberculosis agents. Nature Communications (2017).
4. FunARTS, the Fungal bioActive compound Resistant Target Seeker, an exploration engine for target-directed genome mining in fungi.. Nucleic Acids Research (2023).
5. Discovery of the Azaserine Biosynthetic Pathway Uncovers a Biological Route for α‐Diazoester Production. Angewandte Chemie International Edition (2023).
6. Recent advances in the field of bioactive tetronates. Natural Product Reports (2014).